Access TOC
Get a SampleNovember 2023
The global arterial cannula market size was accounted for USD 33.80 million in 2024, grew to USD 35.43 million in 2025 and is projected to surpass around USD 54.12 million by 2034, representing a CAGR of 4.82% between 2025 and 2034. The North America arterial cannula market size is calculated at USD 13.26 million in 2024 and is expected to grow at a CAGR of 4.81% during the forecast year.
The global arterial cannula market size was estimated at around USD 33.80 million in 2024 and is expected to exceed around USD 54.12 million by 2034, growing at a CAGR of 4.82% from 2025 to 2034. The global arterial cannula market growth is attributed to the increasing prevalence of chronic diseases.
The development of advanced technologies such as machine learning and artificial intelligence in recent years has enabled healthcare professionals to make data-driven and more effective decisions in the arterial cannula market. Thus, cardiology is a specialty that needs the adoption of AI-based systems to offer precise management, especially in chronic diseases such as atrial fibrillation (AF) and coronary artery disease (CAD). In addition, AI-based solutions are easily applicable to remote monitoring, procedural guidance, choice and diagnosis of therapy, and risk assessment in CAD patients in the arterial cannula.
To detect CAD risk factors, AI technologies examine vast volumes of data in the arterial cannula market, such as genetic information, imaging investigations, laboratory findings, and medical history. For example, recent studies have employed deep learning to predict CAD risk by utilizing data from the electronic health records of over 25,000 patients. Therefore, AI will offer physicians a thorough understanding of patient-level data, especially in chronic diseases such as AF and CAD.
The U.S. arterial cannula market size was exhibited at USD 11.00 million in 2024 and is projected to be worth around USD 17.62 million by 2034, growing at a CAGR of 4.83% from 2025 to 2034.
North America dominated the global arterial cannula market in 2023. The market growth in the region is attributed to the growing geriatric population, increasing high surgical procedure rates, and the rising advanced healthcare infrastructure. In addition, the increasing prevalence of cardiovascular diseases and the increasing adoption of minimally invasive surgeries are further expected to drive market growth in the region. Furthermore, an increasing emphasis on patient safety and favorable reimbursement policies further enhances the market demand. The U.S. and Canada are the major countries in terms of market growth. The rising technological advancements and increasing research and development activities in the region.
Asia Pacific is expected to grow at the fastest rate in the market during the forecast period. Thisgrowth is attributed to the growing geriatric population and the increasing prevalence of diabetes and cardiovascular diseases. Furthermore, a growing focus on minimally invasive procedures, increasing access to advanced medical technologies, and improving healthcare infrastructure are further expected to accelerate the market growth. In addition, China, India, Japan, and South Korea are the major countries driving the market growth. China and India are the fastest-growing countries in the healthcare industry.
The arterial cannula market deals with flexible plastic tubes designed to deliver blood to the patient during cardiopulmonary bypass. The process included is called arterial cannulation, which is frequently performed in critical and acute care settings. Arterial cannula is an invasive mean arterial pressure and means to measure blood more accurately than non-invasive means. The prevalence of heart diseases has increased rapidly across the globe due to various factors such as physical inactivity, increasing smoking habits, sedentary lifestyles, consuming unhealthy diets, or family history of chronic diseases such as hyperlipidemia, diabetes, or hypertension contributed to the market growth.
| Report Coverage | Details |
| Market Size by 2034 | USD 54.12 Million |
| Market Size in 2025 | USD 35.43 Million |
| Market Size in 2024 | USD 33.80 Million |
| Market Growth Rate from 2025 to 2034 | CAGR of 4.82% |
| Largest Market | North America |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Size, Application, End-use, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Technological innovations and improvements
The technological innovations and improvements in the arterial cannula market, such as straight tips, tapered collars, and moveable suture rings, are expected to drive the adoption rate. In addition, the rising frequency of cardiopulmonary illnesses enhances performance and maintenance. The increase in the frequency of cardiopulmonary diseases, which leads to a rising number of bypass surgeries across the globe, is further fueling the market growth. In addition, the increasing general population’s sedentary lifestyle, the rising advancements in healthcare facilities in developing countries, and growing healthcare expenditures.
Lack of decentralization of cardiac surgical processes
The limited decentralization of cardiac surgical processes is one of the major challenges restraining the arterial cannula market, thereby negatively driving demand. However, governments, especially developing countries, can invest in outreach clinics for surgeons and specialist physicians to address this gap across the globe. In addition, there is a requirement for a multidisciplinary and comprehensive approach to include rehabilitation and palliative care for patients in remote areas.
The increasing adoption of arterial cannulation in critical care and ICU
Arterial cannulation has become essential for stabilizing and monitoring critically ill patients. If changes in hemodynamic status are not detected, arterial cannulation becomes a standard and necessary treatment in critical care areas for certain populations of patients that are at risk of rapid decline. It is expected to aid in medical decision-making and improve patient outcomes in critical healthcare settings as healthcare professionals become more comfortable with monitoring and arterial cannulation. The adoption of the arterial cannula market has gained traction in recent years, and this is backed by these aspects.
The 20-22 Fr segment dominated the global arterial cannula market in 2023. The segment growth in the market is attributed to the increase in the adoption of cannulas of this size. In addition, the increasing usage of arterial cannulas in extracorporeal membrane oxygenation is further anticipated to drive the segment growth. The demand for these cannulas witnessed a rapid increase.
The 23-25 Fr segment is expected to grow rapidly during the forecast period. The segment growth is attributed to the increased usage of these cannulas in cardiopulmonary bypass surgeries. The growing awareness of advanced surgical techniques, the rise of medical tourism, and enhancements in healthcare facilities facilitate the growing surgeries demand.
The ECMO segment dominated the arterial cannula market in 2023. The segment's growth is driven by the increasing prevalence of lung failures and cardiac diseases. In addition, the increased use of cardiopulmonary bypass and the rising advancement of cardiac surgery are expected to drive the segment's growth. Moreover, various surgeons have illustrated the increasing need to choose the appropriate cannulas and the right cannulation site to ensure proper outcomes.
The cardiopulmonary bypass surgery segment is expected to grow at the fastest rate in the market during the forecast period. The segment growth is attributed to the increasing prevalence of cardiac diseases that need cardiopulmonary bypass surgery. Cardiopulmonary bypass surgery is a process that often supports CABG. Therefore, healthcare providers perform the processes at the same time. The surgery creates a detour for blood to flow away from the lungs and heart. This helps surgeons perform CABG safely and more easily.
The hospitals segment dominated the global arterial cannula market in 2023. The segment growth is attributed to the increase in the number of surgeries performed in these industries. Furthermore, the increasing number of surgical instruments and the availability of all types of skilled professionals are anticipated to enhance the segment growth. Due to the increasing number of diseases, the number of admissions is increasing rapidly.
The ambulatory surgical centers (ASCs) segment is expected to grow significantly during the forecast period. The segment growth in the market is driven by increasing preference for surgeries in ambulatory surgical centers (ASCs). There are various major factors included in the segment growth, such as shorter post-surgery hospital stays and lower overall costs. Furthermore, the increasing government initiatives and policies are further enhancing the segment growth in the market during the forecast period.
By Size
By Application
By End-use
By Geography
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
November 2023
September 2024
December 2024
July 2024